Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.

Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.

J Clin Psychiatry. 1996;57 Suppl 2:46-52.

PMID:
8626363
2.

A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.

Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA.

J Clin Psychiatry. 1998 May;59(5):246-53.

PMID:
9632036
3.

Paroxetine versus placebo: a double-blind comparison in depressed patients.

Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.

J Clin Psychiatry. 1992 Dec;53(12):434-8.

PMID:
1487471
4.

Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.

Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS.

J Clin Psychiatry. 1996;57 Suppl 2:53-62.

PMID:
8626364
5.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
6.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
7.

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.

Weihs KL, Settle EC Jr, Batey SR, Houser TL, Donahue RM, Ascher JA.

J Clin Psychiatry. 2000 Mar;61(3):196-202.

PMID:
10817105
8.

A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.

Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ.

J Clin Psychiatry. 1997 May;58(5):185-92. Erratum in: J Clin Psychiatry 1997 Jun;58(6):275.

PMID:
9184611
9.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
10.

Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.

Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.

J Clin Psychiatry. 1999 Apr;60(4):226-31.

PMID:
10221282
11.
12.

The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.

Ballús C, Quiros G, De Flores T, de la Torre J, Palao D, Rojo L, Gutiérrez M, Casais L, Riesgo Y.

Int Clin Psychopharmacol. 2000 Jan;15(1):43-8.

PMID:
10836286
13.
14.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
15.

A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.

J Clin Psychiatry. 1994 Jun;55(6):234-41.

PMID:
8071277
16.

Mirtazapine compared with paroxetine in major depression.

Benkert O, Szegedi A, Kohnen R.

J Clin Psychiatry. 2000 Sep;61(9):656-63.

PMID:
11030486
17.
18.
19.

A comparison of paroxetine and placebo in depressed outpatients.

Dunbar GC, Claghorn JL, Kiev A, Rickels K, Smith WT.

Acta Psychiatr Scand. 1993 May;87(5):302-5.

PMID:
8517168
20.

Supplemental Content

Support Center